Decibel Therapeutics
Latest round
- Series D
Last raised
- Nov 2020
Total raised
- $188M
Investors
- 17
About Decibel Therapeutics
Based in Massachusetts, US, and was founded in 2015, Decibel Therapeutics, Inc. is a biotechnology company and as of 2021 it has 11 team members, including Senior Director, Product and Market Strategy Erik Larsen, and has 2 board members and advisors, including Anthony Philippakis. In November 2017, Decibel had a strategic partnership with Regeneron Pharmaceuticals, and that gives access to world-leading capabilities in genetics research, drug discovery, and antibody development and manufacturing. In November 2020, Decibel Therapeutics, Inc. Also, In 2021, Decibel Therapeutics became a publicly listed company trading on the Nasdaq under the ticker symbol DBTX. Decibel Therapeutics, Inc. leverages single-cell genomics capabilities through its research, discovery, and drug development platform. The company provides its patients with treatments and medicines for hearing and balance disabilities. Decibel Therapeutics, Inc. is planning to be listed on the Nasdaq under the symbol DBTX.
Who invested in Decibel Therapeutics
17 investors across 5 rounds
See all investors in Decibel Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Decibel Therapeutics
Who invested in Decibel Therapeutics?
Decibel Therapeutics has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Decibel Therapeutics raised?
Decibel Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Decibel Therapeutics last raise money?
Decibel Therapeutics's most recent round on record is a Series D, in Nov 2020.
What does Decibel Therapeutics do?
Based in Massachusetts, US, and was founded in 2015, Decibel Therapeutics, Inc.
Where is Decibel Therapeutics headquartered?
Decibel Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Decibel Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Decibel Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Decibel Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.